Apr 24, 2017Sienna Biopharmaceuticals Announces $40 Million Series B FinancingWESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Sienna Biopharmaceuticals, Inc., a privately held, clinical stage medical dermatology and...